logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » Intensive Statin Therapy May Increase Risk for Diabetes

Intensive Statin Therapy May Increase Risk for Diabetes

In 2011, the Journal of the American Medical Association (JAMA) published a study comparing the impact of intensive-dose and moderate-dose statin therapy and found an increased risk for the development of type 2 diabetes in patients treated with a higher dosage of the drugs.

Statin drugs such as Lipitor, Zocor, Crestor, and Pravachol are commonly used to treat patients with high low-density lipoprotein (LDL) cholesterol. Doctors prescribe these statin drugs along with diet and exercise to reduce the risk of cardiovascular events such as blood clots, blocked arteries, heart attack, and stroke for their patients.

Concern has been growing in the medical community regarding an association between the use of statin drugs and the development of type 2 diabetes. Multiple studies have been conducted using data from as many as thirteen different clinical trials (from 1996-2011) to determine the impact of statin drugs on patients. The study published by JAMA in 2011 was comprised of data from five specific statin trials and confirmed patients on intensive-dose statin drug treatment may have an increased risk for developing diabetes.

Shortly after JAMA released its study in 2011, the U.S. Food and Drug Administration (FDA) issued a safety communication and label change for all statin drugs warning doctors and patients of an increased risk for type 2 diabetes mellitus.
Recent studies have indicated that women taking Lipitor, or other statin drugs, have a higher risk for developing type 2 diabetes—especially those who have a body mass index under 25, which is considered a ‘normal’ weight range.

Our product liability attorneys are investigating claims of women who have been diagnosed with diabetes after taking Lipitor. If you or someone you care about has taken Lipitor and has been diagnosed diabetes, contact us. We have litigated thousands of product liability claims against pharmaceutical companies and medical device manufacturers and can help you obtain compensation for your injuries.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

Former NFL Players Still Have Time to Claim Concussion Settlement Funds

It’s not too late for former National Football League players to claim their funds from the concussion .. Read More

SEE ALL ALERTS

In the News

Indiana Legal Services and Indiana State Bar Foundation Receive $90,000 donation from Cohen & Malad, LLP Class Action United Way of Central Indiana’s Center for Working Families Receives $32,000 from Cohen & Malad, LLP Settlement Funds Indianapolis Neighborhood Housing Partnership Receives $32,000 from Cohen & Malad, LLP Settlement Funds
READ OUR NEWS